Mgc Pharmaceuticals Ltd. (MGCLF) has released an update.
Argent BioPharma Ltd has issued a total of 68,000 unlisted options to key management personnel as part of their managerial compensation. These options are exercisable at A$0.70 and must be used on or before April 1, 2029. The grants were made in accordance with the UK Market Abuse Regulations, and the transactions occurred outside of a trading venue on April 26, 2024.
For further insights into MGCLF stock, check out TipRanks’ Stock Analysis page.
